Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Apple
AAPL
5
Morningstar
MORN
No Data
Express News | Amgen Inc Files for Four Part Notes Offering; Size Not Disclosed - SEC Filing
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 With Advancements in Biologics and JAK Inhibitors | DelveInsight
EUROPÄISCHE KOMMISSION GENEHMIGT UPLIZNA VON AMGEN FÜR GENERALISIERTE MYASTHENIA GRAVIS
Express News | Amgen Inc: Files for Offering Common Stock by the Selling Securityholders - SEC Filing
Express News | Amgen Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing
Amgen | 10-K: FY2025 Annual Report